autologous umbilical cord stem cell therapy (CellPraxis)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameautologous umbilical cord stem cell therapy (CellPraxis)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Neurogenic potential stem cell therapy

Mechanisms of ActionCNS modulators

TargetsUpdating

Therapy Area/IndicationsHypoxia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBrazil

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCellpraxis Bioengenharia Ltda

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCellpraxis Bioengenharia Ltda

Active IndicationsN/A

Inactive IndicationsHypoxia

Other Information

ATC CodeN/A